Curaleaf (OTCMKTS:CURLF) Shares Gap Up – Time to Buy?

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) shares gapped up before the market opened on Thursday . The stock had previously closed at $9.19, but opened at $9.83. Curaleaf shares last traded at $9.67, with a volume of 13,799 shares changing hands.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the stock. Citigroup reaffirmed a “buy” rating on shares of Curaleaf in a research note on Thursday, August 6th. Zacks Research raised shares of Curaleaf from a “hold” rating to a “strong-buy” rating in a report on Tuesday, July 14th. Three equities research analysts have rated the stock with a Strong Buy rating and two have given a Buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Strong Buy”.

Curaleaf Price Performance

The business’s fifty day moving average price is $7.38 and its 200-day moving average price is $7.82. The company has a market capitalization of $2.23 billion, a P/E ratio of -73.44 and a beta of 1.56. The company has a current ratio of 1.52, a quick ratio of 0.73 and a debt-to-equity ratio of 1.06.

Curaleaf (OTCMKTS:CURLF) last released its earnings results on Wednesday, August 5th. The company reported $0.05 EPS for the quarter, beating analysts’ consensus estimates of ($0.20) by $0.25. Curaleaf had a negative return on equity of 0.88% and a negative net margin of 2.62%.The business had revenue of $340.10 million for the quarter, compared to analysts’ expectations of $332.00 million. As a group, sell-side analysts predict that Curaleaf Holdings, Inc. will post -0.04 earnings per share for the current fiscal year.

Curaleaf Company Profile

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.